642 related articles for article (PubMed ID: 12639465)
1. Tubular apocrine adenoma in association with syringocystadenoma papilliferum.
Aktepe F; Demir Y; Dilek FH
Dermatol Online J; 2003 Feb; 9(1):7. PubMed ID: 12639465
[TBL] [Abstract][Full Text] [Related]
2. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands.
Nishie W; Sawamura D; Mayuzumi M; Takahashi S; Shimizu H
J Cutan Pathol; 2004 Sep; 31(8):561-4. PubMed ID: 15268713
[TBL] [Abstract][Full Text] [Related]
3. Syringocystadenoma papilliferum with sebaceous differentiation in an intradermal tubular apocrine component. Report of a case.
Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
Am J Dermatopathol; 2008 Feb; 30(1):51-3. PubMed ID: 18212545
[TBL] [Abstract][Full Text] [Related]
4. [Tubulo-papillary apocrine adenoma in association with syringocystadenoma papilliferum].
Ayadi L; Mallouli M; Kallel R; Charfi S; Makni S; Boudawara TS; Gouiaa N
Ann Pathol; 2016 Oct; 36(5):355-357. PubMed ID: 27693311
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous leiomyosarcoma, trichoblastoma, and syringocystadenoma papilliferum arising from nevus sebaceus.
Premalata CS; Kumar RV; Malathi M; Shenoy AM; Nanjundappa N
Int J Dermatol; 2007 Mar; 46(3):306-8. PubMed ID: 17343592
[TBL] [Abstract][Full Text] [Related]
6. A case of tubular apocrine adenoma with syringocystadenoma papilliferum.
Ansai S; Watanabe S; Aso K
J Cutan Pathol; 1989 Aug; 16(4):230-6. PubMed ID: 2551940
[TBL] [Abstract][Full Text] [Related]
7. Syringocystadenoma papilliferum combined with a tubular apocrine adenoma.
Léda LDSB; Lins MDSVS; Leite EJDS; Cardoso AEC; Houly RLS
An Bras Dermatol; 2017; 92(5):721-723. PubMed ID: 29166517
[TBL] [Abstract][Full Text] [Related]
8. Syringocystadenoma papilliferum associated with apocrine poroma.
Suzuki T; Ikeda H; Hamasaki Y; Hatamochi A; Yamazaki S
J Dermatol; 2006 Apr; 33(4):249-51. PubMed ID: 16674787
[TBL] [Abstract][Full Text] [Related]
9. Tubular apocrine adenoma with eccrine and apocrine immunophenotypes or papillary tubular adenoma?
Tellechea O; Reis JP; Marques C; Baptista AP
Am J Dermatopathol; 1995 Oct; 17(5):499-505. PubMed ID: 8599457
[TBL] [Abstract][Full Text] [Related]
10. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands: report of a case and review of the literature.
Parks A; Branch KD; Metcalf J; Underwood P; Young J
Am J Dermatopathol; 2012 Feb; 34(1):104-9. PubMed ID: 22262361
[TBL] [Abstract][Full Text] [Related]
11. An unusual complex cutaneous adnexal tumor composed of syringocystadenoma papilliferum, apocrine hidrocystoma, and clear cell syringoma.
Lin WL; Lin WC; Kuo TT; Chen CH; Hong HS
Dermatol Surg; 2007 Jul; 33(7):876-9. PubMed ID: 17598859
[No Abstract] [Full Text] [Related]
12. A case of tubular apocrine adenoma with syringocystadenoma papilliferum arising in nevus sebaceus.
Ahn BK; Park YK; Kim YC
J Dermatol; 2004 Jun; 31(6):508-10. PubMed ID: 15235197
[No Abstract] [Full Text] [Related]
13. Congenital papillated apocrine cystadenoma: a mixed form of hidrocystoma, hidradenoma papilliferum, and syringocystadenoma papilliferum.
Schewach-Millet M; Trau H
J Am Acad Dermatol; 1984 Aug; 11(2 Pt 2):374-6. PubMed ID: 6090513
[TBL] [Abstract][Full Text] [Related]
14. A case of sebaceoma with extensive apocrine differentiation.
Tanahashi J; Kashima K; Daa T; Kondoh Y; Yada N; Kuratomi E; Yokoyama S
Am J Dermatopathol; 2008 Aug; 30(4):408-11. PubMed ID: 18645320
[TBL] [Abstract][Full Text] [Related]
15. Is tubular apocrine adenoma a distinct clinical entity?
Ishiko A; Shimizu H; Inamoto N; Nakmura K
Am J Dermatopathol; 1993 Oct; 15(5):482-7. PubMed ID: 8238787
[TBL] [Abstract][Full Text] [Related]
16. Syringocystoadenoma papilliferum associated with apocrine hidrocystoma and verruca.
Arias-Santiago S; Aceituno-Madera P; Aneiros-Fernández J; Gutiérrez-Salmerón MT; Naranjo-Sintes R
Dermatol Online J; 2009 Nov; 15(11):9. PubMed ID: 19951645
[TBL] [Abstract][Full Text] [Related]
17. Naevus sebaceus on the female breast accompanied with a tubular apocrine adenoma and a syringocystadenoma papilliferum.
Yamane N; Kato N; Yanagi T; Osawa R
Br J Dermatol; 2007 Jun; 156(6):1397-9. PubMed ID: 17535243
[No Abstract] [Full Text] [Related]
18. Syringocystadenoma papilliferum of the male breast.
Nowak M; Pathan A; Fatteh S; Fatteh S; Lopez J
Am J Dermatopathol; 1998 Aug; 20(4):422-4. PubMed ID: 9700386
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical detection of carcinoembryonic antigen and protein S-100 in sweat gland tumors].
Haneke E
Z Hautkr; 1986 Jan; 61(1-2):32-46. PubMed ID: 3513457
[TBL] [Abstract][Full Text] [Related]
20. Unique case: syringocystadenoma papilliferum associated with an eccrine nevus.
Philipone E; Chen S
Am J Dermatopathol; 2009 Dec; 31(8):806-7. PubMed ID: 19730225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
